ATARA BIOTHERAPEUTICS, INC. Contract with Customer, Liability, Noncurrent
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Contract with Customer, Liability, Noncurrent of $0 as of 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2025-08-11
- 2025-06-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2025-03-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-09-30: Contract with Customer, Liability, Noncurrent $470.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-Q · filed 2025-08-11 |
| 2024-09-30 | $470.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $567.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $719.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $37.56M 10-K · filed 2025-03-07 |
| 2023-09-30 | $73.93M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $75.56M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $78.04M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $77.00M 10-K · filed 2024-03-28 |
| 2022-09-30 | $42.34M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $43.33M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $45.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $55.71M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $26.84M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $22.47M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $31.81M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $27.80M 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |